San Francisco's health care industry is pulling in new investment, with 23 local companies securing venture capital. New funding rounds were recently announced by health care ventures Ginger, Vim, Decent and Neurona Therapeutics, according to company database Crunchbase.
Ginger topped the city's recent funding headlines by announcing a $35 million Series C round on Sept. 4, led by WP Global Partners.
According to its Crunchbase profile, "Ginger is proven to help people get better by providing on-demand coaching, teletherapy, telepsychiatry and guided self-care — right through a smartphone."
The eight-year-old company has raised six previous funding rounds, including a $20 million Series B round in 2014.
Next up, Vim raised $24 million in Series B funding, in a round announced on Sept. 9 and led by Optum Ventures.
According to Crunchbase, "Vim offers a health care technology platform that aligns incentives between payers and health care providers to enable value-based care decisions."
Founded in 2015, the company has raised two previous rounds, including a $10 million round in 2016.
Meanwhile, Decent raised $8 million in seed funding, announced on Aug. 27.
From the company's Crunchbase profile: "Decent will offer more affordable health care by aligning incentives to improve health, reduce costs and put members at the center of their care."
Decent last raised $8 million in seed funding in 2018.
Also of note, therapeutics company Neurona Therapeutics raised $50,000 in grant funding, announced on Sept. 9 and financed by South Carolina Research Authority.
From Crunchbase: "Neurona Therapeutics is a pre-clinical-stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease."
The company previously raised $1.5 million in a grant in 2018.
Across the industry, San Francisco-based health care companies have raised $211 million in venture funding over the past month, and $4.8 billion over the past year.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
